Search - tctmd.com

Displaying 1 - 20 of 87

Sort: Relevancy | Date

Presentation TCT 2025

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

Presenter: Bo Song

October 28, 2025

Presentation TCT 2025

TCT 1763: Complex Patient With Low Left Ventricular Ejection Fraction and Three-vessel Disease

Presenter: Judit Karacsonyi

October 28, 2025

Presentation TCT 2025

TCT 852: Prognostic Value of Transaortic Flow Rate Compared to Ejection Fraction and Stroke Volume Index in Severe Low-Gradient Aortic Stenosis

Presenter: Mohamed Allam

October 28, 2025

Presentation TCT 2025

TCT 854: Dimensionless Index as a Prognostic Marker in Aortic Stenosis With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

Presenter: Hriday Shah

October 28, 2025

Presentation TCT 2025

TCT 847: Redefining Normal: Prognostic Implications of Left Ventricular Ejection Fraction <60% in Severe Aortic Stenosis: Insights from the CURRENT AS Registry-2

Presenter: Tomohiko Taniguchi

October 28, 2025

Presentation TCT 2025

TCT 397: Prognostic Implications of Supernormal Left Ventricular Ejection Fraction in Acute Myocardial Infarction: Insights from a Nationwide Korean Registry

Presenter: Seok Oh

October 27, 2025

Presentation TCT 2025

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

Presenter: Kari A. Saville

October 27, 2025

Presentation TCT 2025

TCT 895: The Diagnostic Utility of Left Ventricular Ejection Fraction to Global Longitudinal Strain Ratio (LVEF/GLS) in Predicting Severity of Stable Coronary Artery Disease: A Cross-Sectional Study

Presenter: Erhan Tenekecioglu

October 27, 2025

Presentation TCT 2025

TCT 530: Predicting Prognosis in Heart Failure Using Left Atrial Volume Index: A Marker Beyond the Ejection Fraction

Presenter: Farrukh Malik

October 27, 2025

Presentation TCT 2025

TCT 558: Low Filling Pressures in Patients with Acute Exacerbation of Heart Failure with Reduced Ejection Fraction (HFrEF) as Identified with a Novel Sensor: A Sub-Analysis of the SEISMIC-HF I Study

Presenter: Anjan Tibrewala

October 26, 2025

Presentation TCT 2025

TCT 650: Target-Trial Emulation of Physiology-Guided PCI and Its Impact in Patients with Heart-Failure with Reduced Ejection Fraction

Presenter: Firas Anaya

October 26, 2025

Presentation TCT 2025

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 1808: Novel Mechanical Circulatory Device for High-Risk PCI and Aortic Balloon Valvuloplasty in Patient With Low Ejection Fraction & Severe Aortic Stenosis

Presenter: Tomasz Pawlowski

October 25, 2025

Presentation TCT 2025

TCT 1803: Complete Revascularization in Patients With Two Chronic Total Occlusions and Low Ejection Fraction Supported With a Percutaneous Ventricular Assist Device

Presenter: Jiancheng Xiu

October 25, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

HF Risks Stick Around Even When Ejection Fraction Improves

Todd Neale

August 01, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Caitlin E. Cox

July 14, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

Advertisement

TCT 518: Impact of Left Ventricular Ejection Fraction on Outcomes with Drug-Coated Balloon versus Drug-Eluting Stent for de novo Coronary Artery Disease: Insights from the REC-CAGEFREE I Trial

TCT 1763: Complex Patient With Low Left Ventricular Ejection Fraction and Three-vessel Disease

TCT 852: Prognostic Value of Transaortic Flow Rate Compared to Ejection Fraction and Stroke Volume Index in Severe Low-Gradient Aortic Stenosis

TCT 854: Dimensionless Index as a Prognostic Marker in Aortic Stenosis With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

TCT 847: Redefining Normal: Prognostic Implications of Left Ventricular Ejection Fraction <60% in Severe Aortic Stenosis: Insights from the CURRENT AS Registry-2

TCT 397: Prognostic Implications of Supernormal Left Ventricular Ejection Fraction in Acute Myocardial Infarction: Insights from a Nationwide Korean Registry

TCT 583: Long-term Safety and Efficacy of Renal Sympathetic Denervation in Patients with Heart Failure with Reduced Ejection Fraction: 5-year results from the IMPROVE-HF-I study

TCT 895: The Diagnostic Utility of Left Ventricular Ejection Fraction to Global Longitudinal Strain Ratio (LVEF/GLS) in Predicting Severity of Stable Coronary Artery Disease: A Cross-Sectional Study

TCT 530: Predicting Prognosis in Heart Failure Using Left Atrial Volume Index: A Marker Beyond the Ejection Fraction

TCT 558: Low Filling Pressures in Patients with Acute Exacerbation of Heart Failure with Reduced Ejection Fraction (HFrEF) as Identified with a Novel Sensor: A Sub-Analysis of the SEISMIC-HF I Study

TCT 650: Target-Trial Emulation of Physiology-Guided PCI and Its Impact in Patients with Heart-Failure with Reduced Ejection Fraction

TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk

TCT 1808: Novel Mechanical Circulatory Device for High-Risk PCI and Aortic Balloon Valvuloplasty in Patient With Low Ejection Fraction & Severe Aortic Stenosis

TCT 1803: Complete Revascularization in Patients With Two Chronic Total Occlusions and Low Ejection Fraction Supported With a Percutaneous Ventricular Assist Device

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

HF Risks Stick Around Even When Ejection Fraction Improves

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content